To determine the prognostic value of YAP1 and NMU expression in patients with pancreatic cancer, we compared the outcomes of patients with low expression (n = 87) and high expression (n = 87) of these proteins. The gene discussed is YAP1; the disease is familial pancreatic carcinoma.